A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

• Joshua F. Zeidner,
• Tara L. Lin,
• Carlos E. Vigil,
• Gil Fine,
• M. Yair Levy,
• Aziz Nazha,
• Jordi Esteve,
• Daniel J. Lee,
• Karen Yee,
• Andrew Dalovisio,
• Eunice S. Wang,
• Juan M. Bergua Burgues,
• Jeffrey Schriber,
• Mark R. Litzow,
• Olga Frankfurt,
• Teresa Bernal Del Castillo,
• Vijaya Raj Bhatt,
• Bhavana Bhatnagar,
• Priyanka Mehta,
• Richard Dillon,
• Maria Vidriales Vicente,
• Stephen Anthony,
• David Bearss,
• Pau Montesinos,
• B. Douglas Smith

Affiliations

Joshua F. Zeidner

University of North Carolina, Lineberger Comprehensive Cancer Center

Tara L. Lin

University of Kansas Medical Center

Carlos E. Vigil

University of Iowa

Gil Fine

Sumitomo Dainippon Pharma Oncology

M. Yair Levy

Texas Oncology-Baylor Charles A. Sammons Cancer Center

Aziz Nazha

Cleveland Clinic, Taussig Cancer Institute

Jordi Esteve

Hospital Clinic de Barcelona, Universitat de Barcelona

Daniel J. Lee

Columbia University Irving Medical Center

Karen Yee

Princess Margaret Cancer Centre

Andrew Dalovisio

Ochsner Medical Center

Eunice S. Wang

Roswell Park Comprehensive Cancer Center

Juan M. Bergua Burgues

Hospital San Pedro de Alacantra

Jeffrey Schriber

Cancer Treatment Centers of America

Mark R. Litzow

Mayo Clinic

Olga Frankfurt

Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine

Teresa Bernal Del Castillo

Hospital Universitario Central de Asturias

Vijaya Raj Bhatt

Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center

Bhavana Bhatnagar

The Ohio State University Comprehensive Cancer Center

Priyanka Mehta

University Hospitals Bristol

Richard Dillon

Department of Medical and Molecular Genetics, King’s College

Maria Vidriales Vicente

Hospital Clinico Universitario de Salamanca

Stephen Anthony

Sumitomo Dainippon Pharma Oncology

David Bearss

Sumitomo Dainippon Pharma Oncology

Pau Montesinos

Hospital Universitario Politecnico La Fe

B. Douglas Smith

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine